[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@MSollender Avatar @MSollender Michelle Solly

Michelle Solly posts on X about $abvx, $dyn, $rare, debt the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXX% cryptocurrencies XXX%

Social topic influence $abvx 4.5%, $dyn #1, $rare 2.7%, debt 1.8%, dyne therapeutics #1, $atai 1.8%, atai life 1.8%, investment 1.8%, $atyr 1.8%, $cytk XXX%

Top accounts mentioned or mentioned by @semodough @pickingmyown @sanctuary_bio @bigchodu @pcmbio @jacobplieth @sportsbios @biotenic @jq1234t @amaymd @lifeisblank21 @mtheory11bio @ryansttrader @john_hersc79276 @articainabf @biowino @crocsanalyst @pawcio2009 @dmitrykovalchuk @dubmarine72

Top assets mentioned Dyne Therapeutics, Inc. Common Stock (DYN) SuperRare (RARE) ATAI Life Sciences (ATAI) Cytokinetics Inc. (CYTK) Arvinas, Inc (ARVN) Bristol-Myers Squibb Co (BMY) Apogee Therapeutics, Inc. Common Stock (APGE) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Scholar Rock Holding Corporation Common Stock (SRRK) Eli Lilly and Company (LLY) Avidity Biosciences, Inc. Common Stock (RNA) BridgeBio Pharma, Inc. Common Stock (BBIO) Sanofi (SNY) Axsome Therapeutics, Inc (AXSM) Gilead Sciences, Inc. (GILD) Kymera Therapeutics, Inc. Common Stock (KYMR) Pfizer, Inc. (PFE)

Top Social Posts #


Top posts by engagements in the last XX hours

"$MREO $RARE Ultragenyx and Mereo BioPharma Announce UX143 Phase X Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis"
@MSollender Avatar @MSollender on X 2025-07-09 20:07:02 UTC 13.2K followers, 16.7K engagements

"$ATAI atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression"
@MSollender Avatar @MSollender on X 2025-07-01 10:18:33 UTC 13.2K followers, 1988 engagements

"$DYN Dyne Therapeutics Secures Up to $XXX Million in Debt Financing from Hercules Capital"
@MSollender Avatar @MSollender on X 2025-06-30 20:03:21 UTC 13.2K followers, 5485 engagements

"$ABVX XX mg once-daily dose of obefazimod led to a compelling pooled XXXX% (p0.0001) placebo-adjusted clinical remission rate at Week X in the ABTECT-1 (Study 105) and ABTECT-2 (Study 106) trials"
@MSollender Avatar @MSollender on X 2025-07-22 20:13:13 UTC 13.2K followers, 2595 engagements

"$ATAI atai Life Sciences Announces $XX Million Private Placement Financing Ferring Ventures S.A. and Apeiron Investment Ltd. with Ally Bridge Group and ADAR1"
@MSollender Avatar @MSollender on X 2025-07-01 10:19:01 UTC 13.2K followers, 3192 engagements

"$BMY Bristol Myers Squibb Announces Topline Results from Phase X ARISE Trial Evaluating Cobenfy (xanomeline and trospium chloride) as an Adjunctive Treatment to Atypical Antipsychotics in Adults with Schizophrenia Fail"
@MSollender Avatar @MSollender on X 2025-04-22 20:21:39 UTC 13.2K followers, 3474 engagements

"$ABVX Abivax Announces Positive Phase X Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod its First-in-Class Oral miR-124 Enhancer in Moderate to Severely Active Ulcerative Colitis"
@MSollender Avatar @MSollender on X 2025-07-22 20:12:22 UTC 13.2K followers, 12.7K engagements

"(1/3) Wow second half of the year already Here are some catalysts for 3Q25 Those in 4Q25 are not listed. The ones in the nice calming blue are those I have my eye on $ABUS $ABVX $AMLX $APGE $ATYR $CAPR $COGT $CRDF $FULC $KALA $MLTX $NEUP $OMER $RARE $REPL $SRRK $VYNE"
@MSollender Avatar @MSollender on X 2025-07-01 11:11:51 UTC 13.2K followers, 52.7K engagements

"$RNA Maybe a second trip Just guessing here and $DYN sympathy"
@MSollender Avatar @MSollender on X 2025-07-25 18:38:48 UTC 13.2K followers, 10.4K engagements

"$ABVX (Also a highly acquisitive space cough cough). Gonna guess it's not going to be too late to add for a while"
@MSollender Avatar @MSollender on X 2025-07-22 20:18:33 UTC 13.2K followers, 12.1K engagements

"$ADAG Adagene announces up to $XX million strategic investment from Sanofi"
@MSollender Avatar @MSollender on X 2025-07-01 11:02:10 UTC 13.2K followers, 1904 engagements

"$AXSM Axsome Therapeutics Provides Update on the New Drug Application (NDA) for AXS-14 for the Management of Fibromyalgia RTF"
@MSollender Avatar @MSollender on X 2025-06-09 11:02:02 UTC 13.2K followers, 4787 engagements

"$KYMR Interesting Kymera had decided last year not to advance their previous oncology pipeline past Ph1 (MDM2 and STAT3) but now has entered into a collaboration with $GILD for CDK2 degraders $85m upfront up to $750m in milestones"
@MSollender Avatar @MSollender on X 2025-06-25 18:47:27 UTC 13.1K followers, 5471 engagements

"$PFE Pfizer Enters into Exclusive Licensing Agreement with 3SBio SSGJ-707 a bispecific antibody targeting PD-1 and VEGF Upfront payment of $XXXX billion and milestones up to $XXX billion"
@MSollender Avatar @MSollender on X 2025-05-20 00:05:29 UTC 13.2K followers, 58.3K engagements

"Wow $ABVX better than I expected 2/2 so far $ATYR up next in the next 4-6 weeks ✅✅❔"
@MSollender Avatar @MSollender on X 2025-07-22 20:15:53 UTC 13.2K followers, 16.3K engagements

"@lifeisblank21 Numerical without numbers on the graph"
@MSollender Avatar @MSollender on X 2025-07-23 20:53:49 UTC 13.2K followers, XXX engagements

"$RARE Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)"
@MSollender Avatar @MSollender on X 2025-07-11 20:32:41 UTC 13.2K followers, 18.2K engagements

"(2/3) Here are some slated for 2H25 Those that are specifically in 4Q25 are not listed yet $BIOA $CABA $CNTA $DRUG"
@MSollender Avatar @MSollender on X 2025-07-01 11:12:41 UTC 13.2K followers, 3902 engagements

"$CYTK Cytokinetics submitted the NDA for aficamten in oHCM without an accompanying REMS and the FDA accepted the NDA for filing. Recently during the NDA review the FDA requested that Cytokinetics submit a REMS Oh"
@MSollender Avatar @MSollender on X 2025-05-01 20:33:05 UTC 13.1K followers, 8302 engagements